Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Akili, Inc. (AKLI)

1.45   0.06 (4.32%) 01-27 16:00
Open: 1.44 Pre. Close: 1.39
High: 1.52 Low: 1.38
Volume: 104,259 Market Cap: 113(M)

Technical analysis

as of: 2023-01-27 4:42:24 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.84     One year: 2.15
Support: Support1: 1.13    Support2: 0.85
Resistance: Resistance1: 1.58    Resistance2: 1.84
Pivot: 1.39
Moving Average: MA(5): 1.4     MA(20): 1.33
MA(100): 2.01     MA(250): 6.54
MACD: MACD(12,26): 0     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 68.6     %D(3): 65.1
RSI: RSI(14): 53
52-week: High: 37.58  Low: 0.85
Average Vol(K): 3-Month: 165 (K)  10-Days: 70 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ AKLI ] has closed below upper band by 38.6%. Bollinger Bands are 67.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 76 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.52 - 1.53 1.53 - 1.54
Low: 1.36 - 1.37 1.37 - 1.38
Close: 1.44 - 1.45 1.45 - 1.46

Company Description

Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.

Headline News

Sat, 28 Jan 2023
UVA Women's Tennis Clinches Bid to ITA National Indoor Championships - Yardbarker

Sat, 28 Jan 2023
UVA punches ticket to ITA National Team Indoor Championship - - CBS19 News

Sat, 28 Jan 2023
Virginia Women's Tennis | No. 8 Virginia Qualifies for ITA Indoors - Virginia University

Wed, 25 Jan 2023
Tennis Weekly Honors: Jan. 25 - Southeastern Conference

Sun, 22 Jan 2023
Akili, Inc. (NASDAQ:AKLI) Receives Consensus Rating of "Moderate ... - MarketBeat

Sat, 14 Jan 2023
Jackets Collect Wins at Carolina Kickoff – Women's Tennis ... - Georgia Tech

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Outperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Health Information Services
Shares Out. 0 (M)
Shares Float 0 (M)
% Held by Insiders 3.9e+007 (%)
% Held by Institutions 34.5 (%)
Shares Short 50 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -8.118e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -18
Return on Assets (ttm) 268.8
Return on Equity (ttm) 0
Qtrly Rev. Growth 446000
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow 0 (M)
Levered Free Cash Flow -74 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 98860
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.